BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium for various products.
238200 | KO
Overview
Corporate Details
- ISIN(s):
- KR7238200000
- LEI:
- Country:
- South Korea
- Address:
- 강원도 홍천군 홍천읍 농공단지길 23-16, 홍천군
- Website:
- https://bifido.com/
- Sector:
- Manufacturing
Description
BIFIDO Co., Ltd. is a biotechnology company established in 1999 that specializes in the human microbiome. The company's core focus is the research and development of human-derived Bifidobacterium strains for use in functional foods, supplements, and personal care products. BIFIDO operates an integrated platform that covers the entire process from the selection of probiotic and pharmabiotic candidates to the manufacturing of finished goods, marketed under brands like BIFIDOLAB. Its research, supported by extensive scientific papers and patents, targets areas such as immune regulation, cognitive health, and the development of microbiome-based therapeutics for various health conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2020-03-27 00:00 |
[기재정정]주주총회소집결의
|
Korean | HTML • 12.3 KB | ||
| 2020-03-27 00:00 |
[기재정정]주주총회소집공고
|
Korean | HTML • 134.7 KB | ||
| 2020-03-27 00:00 |
정기주주총회결과
|
Korean | HTML • 19.4 KB | ||
| 2020-03-19 00:00 |
주요사항보고서(자기주식취득결정)
|
Korean | HTML • 28.9 KB | ||
| 2020-03-19 00:00 |
감사보고서제출
|
Korean | HTML • 27.0 KB | ||
| 2020-03-19 00:00 |
[기재정정]주요사항보고서(자기주식취득결정)
|
Korean | HTML • 30.7 KB | ||
| 2020-03-19 00:00 |
[기재정정]주주총회소집공고
|
Korean | HTML • 291.9 KB | ||
| 2020-03-12 00:00 |
주주총회소집공고
|
Korean | HTML • 118.4 KB | ||
| 2020-02-27 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | HTML • 12.7 KB | ||
| 2020-02-27 00:00 |
주주총회소집결의
|
Korean | HTML • 8.3 KB | ||
| 2020-02-27 00:00 |
주주총회집중일개최사유신고
|
Korean | HTML • 4.3 KB | ||
| 2020-02-24 00:00 |
기타경영사항(특허권취득)(자율공시)(부티릴 프락토올리고당을 포함하는 프리바이오틱스 조성물)
|
Korean | HTML • 5.3 KB | ||
| 2020-02-03 00:00 |
기타경영사항(특허권취득)(자율공시)(류마티스관절염 개선, 예방 또는 치료를 위한 비피도박테리움 롱검 RAPO 균주 및 이를 포함하는 조성물)
|
Korean | HTML • 5.9 KB | ||
| 2020-01-13 00:00 |
기타경영사항(특허권취득)(자율공시)(비피도박테리움을 함유한 류마티스관절염 개선용, 치료용 또는 예방용 조성물 미국특허 취득)
|
Korean | HTML • 5.2 KB | ||
| 2019-12-06 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | HTML • 4.3 KB |
Automate Your Workflow. Get a real-time feed of all BIFIDO. Co. Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BIFIDO. Co. Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BIFIDO. Co. Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
